PTC Therapeutics Inc (NAS:PTCT)
$ 36.5 -0.23 (-0.63%) Market Cap: 2.81 Bil Enterprise Value: 2.13 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 68/100

PTC Therapeutics Inc PIVOT-HD Interim Data Update Call Transcript

Jun 21, 2023 / 12:00PM GMT
Release Date Price: $43.06 (+2.69%)
Operator

Good day, and welcome to the PIVOT-HD interim data update call. (Operator Instructions) As a reminder, this call is being recorded.

I would now like to turn the call over to CEO, Dr. Matthew Klein. You may begin.

Matthew B. Klein
PTC Therapeutics, Inc. - CEO & Director

Thank you for joining this morning's call. We are excited to share the encouraging data from the 12-week interim analysis of the PIVOT-HD study.

Before I begin, I refer you to our forward-looking statements on this slide, which are also posted on our website as well as our Risk Factors section in our most recent 10-K.

The PTC518 Huntington's disease program comes from PTC's validated splicing classes. PTC pioneered the field of small molecule splicing And over the past 2 decades, -- we have built a robust platform to enable the identification of disease-relevant splicing targets and molecular scaffolds capable of favorably affecting splicing activity. In addition to our platform tools, we also have an outstanding team of scientists who have been leading our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot